GILL DAVID N has filed 21 insider transactions across 2 companies since February 2024.
Most recent transaction: a grant/award of 45559 shares of Evolus, Inc. ($EOLS) on February 17, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | Evolus, Inc. | $EOLS | GILL DAVID N | Director | A | Common Stock | 45559 | $0.00 | 86,887.0000 | 64,819,784 | 110.24% | 0.07% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | GILL DAVID N | Not found | D | Common Stock | 5825 | $8.60 | 0.0000 | 45,318,028 | 100.00% | 0.01% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | GILL DAVID N | Not found | D | Common Stock | 25080 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.06% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | GILL DAVID N | Not found | D | Employee Stock Option (right to buy) | 24000 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.05% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | GILL DAVID N | Not found | D | Employee Stock Option (right to buy) | 16000 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.04% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | GILL DAVID N | Not found | D | Employee Stock Option (right to buy) | 11000 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.02% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | GILL DAVID N | Not found | D | Employee Stock Option (right to buy) | 11000 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.02% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | GILL DAVID N | Not found | D | Employee Stock Option (right to buy) | 16000 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.04% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | GILL DAVID N | Not found | D | Employee Stock Option (right to buy) | 13950 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.03% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | GILL DAVID N | Not found | D | Employee Stock Option (right to buy) | 14545 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.03% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | GILL DAVID N | Not found | D | Employee Stock Option (right to buy) | 33450 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.07% |
| June 30, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | GILL DAVID N | Not found | A | Common Stock | 25080 | $0.00 | 30,905.0000 | 45,104,476 | 430.56% | 0.06% |
| June 30, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | GILL DAVID N | Not found | A | Employee Stock Option (right to buy) | 33450 | $0.00 | 33,450.0000 | 45,104,476 | 9999.99% | 0.07% |
| March 7, 2025 | Evolus, Inc. | $EOLS | GILL DAVID N | Director | A | Common Stock | 7364 | $0.00 | 41,328.0000 | 63,586,753 | 21.68% | 0.01% |
| March 7, 2025 | Evolus, Inc. | $EOLS | GILL DAVID N | Director | A | Stock Option (Right to Buy) | 11146 | $0.00 | 11,146.0000 | 63,586,753 | 9999.99% | 0.02% |
| June 11, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | GILL DAVID N | Director | A | Common Stock | 3495 | $0.00 | 5,825.0000 | 43,779,456 | 150.00% | 0.01% |
| June 11, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | GILL DAVID N | Director | A | Employee Stock Option (right to buy) | 14545 | $0.00 | 14,545.0000 | 43,779,456 | 9999.99% | 0.03% |
| May 14, 2024 | Evolus, Inc. | $EOLS | GILL DAVID N | Director | S | Common Stock | 6718 | $12.60 | 33,964.0000 | 0 | 16.51% | 0.00% |
| May 13, 2024 | Evolus, Inc. | $EOLS | GILL DAVID N | Director | S | Common Stock | 3643 | $12.72 | 40,682.0000 | 0 | 8.22% | 0.00% |
| Feb. 7, 2024 | Evolus, Inc. | $EOLS | GILL DAVID N | Director | A | Stock Option (Right to Buy) | 9377 | $0.00 | 9,377.0000 | 0 | 9999.99% | 0.00% |
| Feb. 7, 2024 | Evolus, Inc. | $EOLS | GILL DAVID N | Director | A | Common Stock | 6464 | $0.00 | 44,325.0000 | 0 | 17.07% | 0.00% |